Agios Presents Updated Data from the Ivosidenib Phase 1 Dose-Escalation and Expansion Trial Life Science Investing
Eyenovia Completes Patient Enrollment in MicroStat MIST-1 Study and Enrolls First Patient in MIST-2 Study Pharmaceutical Investing
Zogenix Announces Positive Phase 3 Trial Results on the Efficacy and Safety of FINTEPLA (ZX008) in Dravet Syndrome Life Science Investing
Adverum Biotechnologies Announces Publication of Preclinical Long-Term Expression and Efficacy Data in Molecular Therapy Life Science Investing
Isodiol International Inc. Announces Closing of $6,000,000 Convertible Debenture Offering Cannabis Investing News
Life Science Big News Roundup: Lexaria Bioscience Submits Application to Health Canada for Research License; NanoSphere Develops New Product Eliminating Need to Smoke Cannabis Life Science Investing
Shire Receives European Approval for TAKHZYRO (lanadelumab) subcutaneous injection Life Science Investing
Principia Biopharma Reports Positive PRN1008 Phase 2 Top-Line Results and Initiates Phase 3 Pemphigus Program Pharmaceutical Investing
